InhalPlus Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$562K
- Investors
-
7
InhalPlus General Information
Description
Operator of a medical device technology intended to improve non-invasive inhalation therapy for preterm infants, newborns, and adults requiring respiratory support. The company offers a patented aerosol delivery system with bypass technology that prevents medication dilution in ventilation circuits, supports continuous respiratory assistance, and delivers concentrated medication directly to the lungs, enabling hospitals, neonatal intensive care units, and respiratory care providers to improve drug delivery and reduce reliance on invasive treatments.
Contact Information
Website
www.inhalplus.comCorporate Office
- Fichtestraße 37
- 30625 Hanover
- Germany
Corporate Office
- Fichtestraße 37
- 30625 Hanover
- Germany
InhalPlus Timeline
InhalPlus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Seed Round | 26-Oct-2026 | $562K | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | 15-May-2025 | Completed | Startup | |||
| 5. Seed Round | 01-May-2025 | Completed | Startup | |||
| 4. Grant | 01-Apr-2025 | Completed | Startup | |||
| 3. Grant | 01-Dec-2024 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2023 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
InhalPlus Signals
InhalPlus Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NBank Capital | Venture Capital | Minority | ||
| HGS START accelerator | Accelerator/Incubator | Minority | ||
| Fraunhofer Venture | Venture Capital | Minority | ||
| Institute for Biomedical Translation | Corporation | |||
| Germany's Federal Ministry of Economics and Technology | Government |
InhalPlus FAQs
-
When was InhalPlus founded?
InhalPlus was founded in 2023.
-
Where is InhalPlus headquartered?
InhalPlus is headquartered in Hanover, Germany.
-
What is the size of InhalPlus?
InhalPlus has 4 total employees.
-
What industry is InhalPlus in?
InhalPlus’s primary industry is Medical Supplies.
-
Is InhalPlus a private or public company?
InhalPlus is a Private company.
-
What is InhalPlus’s current revenue?
The current revenue for InhalPlus is .
-
How much funding has InhalPlus raised over time?
InhalPlus has raised $580K.
-
Who are InhalPlus’s investors?
NBank Capital, HGS START accelerator, Fraunhofer Venture, Institute for Biomedical Translation, and Germany's Federal Ministry of Economics and Technology are 5 of 7 investors who have invested in InhalPlus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process